Buscar
Biote Corp
BTMDAñadir a la lista de seguimiento
2.250USD
+0.030+1.35%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
69.03MCap. mercado
4.47P/E TTM
Más Datos de Biote Corp Compañía
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Información de Biote Corp
Símbolo de cotizaciónBTMD
Nombre de la empresaBiote Corp
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoChristensen (Bret)
Número de empleados217
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 02
Dirección1875 W. Walnut Hill Ln #100
CiudadIRVING
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75038
Teléfono19724869346
Sitio Webhttps://haymakeracquisition.com/
Símbolo de cotizaciónBTMD
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoChristensen (Bret)
Ejecutivos de Biote Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--
Ms. Debra L. Morris
Ms. Debra L. Morris
Independent Director
Independent Director
--
--
Ms. Dana Jacoby
Ms. Dana Jacoby
Independent Director
Independent Director
--
--
Dr. S. Mark Cone
Dr. S. Mark Cone
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Biote Corp?
Los cinco principales accionistas de Biote Corp son: Mr. Andrew R. (Andy) Heyer
¿Cuántas instituciones poseen acciones de Biote Corp (BTMD)?
A fecha de 2026Q1, 214 instituciones poseen acciones de Biote Corp, con un valor de mercado combinado de aproximadamente 20.55M, lo que representa el 64.13% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2349533.00.
¿Cuál es la mayor fuente de ganancias de Biote Corp?
El 2026Q1, el segmento empresarial Pellet Procedures generó la ganancia más alta para Biote Corp, ascendiendo a 137.04M y representando el 71.29% de la ganancia total.